Pedro Villarejo‐Campos

Efficacy and Safety of Intraoperative Hyperthermic Intraperitoneal Chemotherapy for Locally Advanced Colon Cancer

Álvaro Arjona‐Sánchez, Esther Espinosa-Redondo, Alberto Gutiérrez‐Calvo et al. · JAMA Surgery · 2023 · 102 citations · Full text

HIPECT4: multicentre, randomized clinical trial to evaluate safety and efficacy of Hyperthermic intra-peritoneal chemotherapy (HIPEC) with Mitomycin C used during surgery for treatment of locally advanced colorectal carcinoma

Álvaro Arjona‐Sánchez, P. Barrios, Emrique Boldo-Roda et al. · BMC Cancer · 2018 · 96 citations · Full text

Prognostic implications of serum microRNA-21 in colorectal cancer

Pablo Menéndez, David Padilla, Pedro Villarejo‐Campos et al. · Journal of Surgical Oncology · 2013 · 80 citations

GECOP-MMC: phase IV randomized clinical trial to evaluate the efficacy of hyperthermic intraperitoneal chemotherapy (HIPEC) with mytomicin-C after complete surgical cytoreduction in patients with colon cancer peritoneal metastases

Fernando Pereira, Ángel Serrano, Israel Manzanedo et al. · BMC Cancer · 2022 · 51 citations · Full text

RAS Mutation Decreases Overall Survival After Optimal Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy of Colorectal Peritoneal Metastasis: A Modification Proposal of the Peritoneal Surface Disease Severity Score

Álvaro Arjona‐Sánchez, Lidia Rodríguez‐Ortiz, Dario Baratti et al. · Annals of Surgical Oncology · 2019 · 34 citations

Surgical Oncology, Optimal Cytoreductive Surgery, Gastrointestinal Oncology +9